Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant

Researchers evaluated anti–SARS-CoV-2 spike protein receptor binding domain and neutralizing antibody responses to COVID-19 vaccines longitudinally over six months in patients with cancer undergoing treatment or who received a stem cell transplant.